TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kilitch Drugs (India) Limited ( (IN:KILITCH) ) just unveiled an update.
Kilitch Drugs (India) Limited announced a postponement in the credit and listing dates for its Rights Issue shares, initially scheduled for August 25 and 26, 2025, now moved to August 26 and 28, 2025. This delay, related to the finalization of the basis of allotment, may impact shareholders and market expectations, as the company had previously communicated the Rights Issue details and schedule.
More about Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited operates in the pharmaceutical industry, focusing on the production and distribution of various pharmaceutical products. The company is known for its commitment to quality and has certifications such as ISO 9001:2008 and WHO certification, positioning itself as a reliable player in the global pharmaceutical market.
Average Trading Volume: 3,224
Technical Sentiment Signal: Buy
Current Market Cap: 7.08B INR
For detailed information about KILITCH stock, go to TipRanks’ Stock Analysis page.